No Data
No Data
10-Q: Q3 2025 Earnings Report
Express News | Nutriband Q3 EPS $(0.12) Up From $(0.22) YoY, Sales $645.80K Up From $427.84K YoY
Nutriband Inc. Quarterly Report Highlights Record Revenue for Q3 up 50.94% YOY and Strategic Progress Toward NDA Filing for AVERSA Fentanyl in 2025
12 Health Care Stocks Moving In Friday's Pre-Market Session
Express News | Nutriband Secures Hong Kong Patent for Aversa Technology, Expanding Global IP Portfolio Across 46 Countries
Nutriband Receives Costa Rica MoH Approval for Mosquito Repellent Patch